| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.2 | 4e-05 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.095 | 0.001 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |